Becton Dickinson
Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BDX
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional.
BDX Key Statistics
Stock Snapshot
The current Becton Dickinson(BDX) stock price is $175.89, with a market capitalization of 50.04B. The stock trades at a price-to-earnings (P/E) ratio of 28.73 and offers a dividend yield of 2.4%.
On 2026-02-15, Becton Dickinson(BDX) stock moved within a range of $175.72 to $180.23. With shares now at $175.89, the stock is trading +0.1% above its intraday low and -2.4% below the session's peak.
Trading volume for Becton Dickinson(BDX) stock has reached 3.08M, versus its average volume of 4.31M.
The stock's 52-week range extends from a low of $129.03 to a high of $187.10.
The stock's 52-week range extends from a low of $129.03 to a high of $187.10.
BDX News
Becton Dickinson (BDX) has drawn fresh attention after recent trading left the shares with a year to date total return nearly 9% lower, despite a roughly 3% gai...
Citi analyst Joanne Wuensch raised the firm’s price target on Becton Dickinson (BDX) to $198 from $185.70 and keeps a Buy rating on the shares. The firm updated...
The latest update is out from Becton Dickinson ( (BDX) ). On February 10, 2026, BD launched a series of cash tender offers for up to $1.6 billion in aggregate...
Analyst ratings
61%
of 18 ratingsMore BDX News
The company reported sales of $5.25 billion, slightly above the consensus of $5.15 billion. Guidance Becton Dickinson lowers fiscal 2026 adjusted earnings gui...
Becton Dickinson (NYSE:BDX) has completed a $17.5b spin off and merger of its Biosciences and Diagnostic Solutions businesses with Waters. The deal restructure...
In trading on Tuesday, shares of Becton, Dickinson & Co (Symbol: BDX) crossed below their 200 day moving average of $187.19, changing hands as low as $164.41 pe...
Barclays analyst Matt Miksic reinstated coverage of Becton Dickinson (BDX) with an Overweight rating and $202 price target after the company sold its LifeScienc...
Becton, Dickinson and Company reported first-quarter 2026 results on February 9, 2026, with sales rising to US$5,252 million and net income reaching US$382 mill...
U.S. stocks traded mixed this morning, with the Dow Jones index falling around 250 points on Monday. Following the market opening Monday, the Dow traded down 0...
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.